{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:50:28Z","timestamp":1791229828170,"version":"4.1.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,11,11]],"date-time":"2012-11-11T00:00:00Z","timestamp":1352592000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00401-012-1066-5","type":"journal-article","created":{"date-parts":[[2012,11,10]],"date-time":"2012-11-10T07:21:22Z","timestamp":1352532082000},"page":"763-775","source":"Crossref","is-referenced-by-count":221,"title":["Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited"],"prefix":"10.1007","volume":"124","author":[{"given":"Karl H.","family":"Plate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,11]]},"reference":[{"issue":"5","key":"1066_CR1","doi-asserted-by":"crossref","first-page":"a001875","DOI":"10.1101\/cshperspect.a001875","volume":"2","author":"RH Adams","year":"2010","unstructured":"Adams RH, Eichmann A (2010) Axon guidance molecules in vascular patterning. Cold Spring Harb Perspect Biol 2(5):a001875","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5302","key":"1066_CR2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","volume":"275","author":"T Asahara","year":"1997","unstructured":"Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964\u2013967","journal-title":"Science"},{"issue":"7","key":"1066_CR3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacc.2012.02.053","volume":"60","author":"JT Belcik","year":"2012","unstructured":"Belcik JT, Qi Y, Kaufmann BA et al (2012) Cardiovascular and systemic microvascular effects of anti-vascular endothelial growth factor therapy for cancer. J Am Coll Cardiol 60(7):618\u2013625","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1066_CR4","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2009.03.025","volume":"137","author":"R Benedito","year":"2009","unstructured":"Benedito R, Roca C, S\u00f6rensen I, Adams S, Gossler A, Fruttiger M, Adams RH (2009) The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137(6):1124\u20131135","journal-title":"Cell"},{"issue":"7392","key":"1066_CR5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature10908","volume":"484","author":"R Benedito","year":"2012","unstructured":"Benedito R, Rocha SF, Woeste M, Zamykal M, Radtke F, Casanovas O, Duarte A, Pytowski B, Adams RH (2012) Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF\u2013VEGFR2 signalling. Nature 484(7392):110\u2013114","journal-title":"Nature"},{"issue":"9","key":"1066_CR6","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1242\/dev.125.9.1591","volume":"125","author":"LE Benjamin","year":"1998","unstructured":"Benjamin LE, Hemo I, Keshet E (1998) A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125(9):1591\u20131598","journal-title":"Development"},{"issue":"8","key":"1066_CR7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","volume":"8","author":"G Bergers","year":"2008","unstructured":"Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8(8):592\u2013603","journal-title":"Nat Rev Cancer"},{"key":"1066_CR8","doi-asserted-by":"crossref","unstructured":"Blanco R, Gerhardt H (2012) VEGF and Notch in tip and stalk cell selection. Cold Spring Harb Perspect Med October 1\u201320 (published online)","DOI":"10.1101\/cshperspect.a006569"},{"issue":"6940","key":"1066_CR9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/423593a","volume":"423","author":"DP Bottaro","year":"2003","unstructured":"Bottaro DP, Liotta LA (2003) Cancer: out of air is not out of action. Nature 423(6940):593\u2013595","journal-title":"Nature"},{"issue":"3","key":"1066_CR10","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/0008-5472.CAN-03-2073","volume":"64","author":"DJ Brat","year":"2004","unstructured":"Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH, Devi SN, Kaur B, Van Meir EG (2004) Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64(3):920\u2013927","journal-title":"Cancer Res"},{"issue":"4\u20135","key":"1066_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0463.2004.apm11204-0505.x","volume":"112","author":"H Broholm","year":"2004","unstructured":"Broholm H, Laursen H (2004) Vascular endothelial growth factor (VEGF) receptor neuropilin-1\u2019s distribution in astrocytic tumors. APMIS 112(4\u20135):257\u2013263","journal-title":"APMIS"},{"issue":"1","key":"1066_CR12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1158\/1535-7163.MCT-09-0554","volume":"9","author":"JL Brown","year":"2010","unstructured":"Brown JL, Cao ZA, Pinzon-Ortiz M et al (2010) A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models. Mol Cancer Ther 9(1):145\u2013156","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"1066_CR13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng1395","volume":"36","author":"L Cao","year":"2004","unstructured":"Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D, During MJ (2004) VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet 36(8):827\u2013835","journal-title":"Nat Genet"},{"issue":"6573","key":"1066_CR14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/380435a0","volume":"380","author":"P Carmeliet","year":"1996","unstructured":"Carmeliet P, Ferreira V, Breier G et al (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380(6573):435\u2013439","journal-title":"Nature"},{"issue":"7347","key":"1066_CR15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298\u2013307","journal-title":"Nature"},{"issue":"6","key":"1066_CR16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrclinonc.2009.64","volume":"6","author":"P Carmeliet","year":"2009","unstructured":"Carmeliet P, De Smet F, Loges S, Mazzone M (2009) Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way. Nat Rev Clin Oncol 6(6):315\u2013326","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"1066_CR17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.2011.38.7621","volume":"30","author":"T Cascone","year":"2012","unstructured":"Cascone T, Heymach JV (2012) Targeting the Angiopoietin\/Tie2 pathway: cutting tumor vessels with a double-edged sword? J Clin Oncol 30(4):441\u2013444","journal-title":"J Clin Oncol"},{"issue":"14","key":"1066_CR18","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-09-3073","volume":"16","author":"SS Chae","year":"2010","unstructured":"Chae SS, Kamoun WS, Farrar CT, Kirkpatrick ND, Niemeyer E, de Graaf AMA, Sorensen AG, Munn LL, Jain RK, Fukumura D (2010) Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas. Clin Cancer Res 16(14):3618\u20133627","journal-title":"Clin Cancer Res"},{"key":"1066_CR19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4137\/CMO.S7232","volume":"5","author":"MC Chamberlain","year":"2011","unstructured":"Chamberlain MC (2011) Bevacizumab for the treatment of recurrent glioblastoma. Clin Med Insights Oncol 5:117\u2013129","journal-title":"Clin Med Insights Oncol"},{"issue":"1","key":"1066_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccr.2012.06.011","volume":"22","author":"L Claesson-Welsh","year":"2012","unstructured":"Claesson-Welsh L (2012) Receptor talk and tumor cell walk in glioblastoma. Cancer Cell 22(1):1\u20132","journal-title":"Cancer Cell"},{"issue":"13","key":"1066_CR21","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1158\/0008-5472.CAN-10-0012","volume":"70","author":"SB Coffelt","year":"2010","unstructured":"Coffelt SB, Tal AO, Scholz A et al (2010) Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions. Cancer Res 70(13):5270\u20135280","journal-title":"Cancer Res"},{"issue":"1","key":"1066_CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ydbio.2011.06.045","volume":"358","author":"DC Darland","year":"2011","unstructured":"Darland DC, Cain JT, Berosik MA, Saint-Geniez M, Odens PW, Schaubhut GJ, Frisch S, Stemmer-Rachamimov A, Darland T, D\u2019Amore PA (2011) Vascular endothelial growth factor (VEGF) isoform regulation of early forebrain development. Dev Biol 358(1):9\u201322","journal-title":"Dev Biol"},{"issue":"1","key":"1066_CR23","first-page":"1","volume":"21","author":"K Bock De","year":"2010","unstructured":"De Bock K, Cauwenberghs S, Carmeliet P (2010) Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications. Curr Opin Genet Dev 21(1):1\u20137","journal-title":"Curr Opin Genet Dev"},{"issue":"3","key":"1066_CR24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/neuonc\/nop027","volume":"12","author":"JF Groot de","year":"2010","unstructured":"de Groot JF, Fuller G, Kumar AJ, Piao Y, Eterovic K, Ji Y, Conrad CA (2010) Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro Oncol 12(3):233\u2013242","journal-title":"Neuro Oncol"},{"issue":"14","key":"1066_CR25","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1158\/1078-0432.CCR-11-0271","volume":"17","author":"JF Groot de","year":"2011","unstructured":"de Groot JF, Piao Y, Tran H et al (2011) Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept. Clin Cancer Res 17(14):4872\u20134881","journal-title":"Clin Cancer Res"},{"issue":"7343","key":"1066_CR26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/472303a","volume":"472","author":"M Palma De","year":"2011","unstructured":"De Palma M, Lewis CE (2011) Cancer: macrophages limit chemotherapy. Nature 472(7343):303\u2013304","journal-title":"Nature"},{"key":"1066_CR27","doi-asserted-by":"crossref","unstructured":"De Palma M, Coukos G, Semela D (2012) TIE2-expressing monocytes: A novel cellular biomarker for hepatocellular carcinoma? Hepatology. doi: 10.1002\/hep.26025","DOI":"10.1002\/hep.26025"},{"issue":"12","key":"1066_CR28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.it.2007.09.004","volume":"28","author":"M Palma De","year":"2007","unstructured":"De Palma M, Murdoch C, Venneri MA, Naldini L, Lewis CE (2007) Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol 28(12):519\u2013524","journal-title":"Trends Immunol"},{"issue":"3","key":"1066_CR29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","volume":"8","author":"M Palma De","year":"2005","unstructured":"De Palma M, Venneri MA, Galli R, Sergi LS, Politi LS, Sampaolesi M, Naldini L (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8(3):211\u2013226","journal-title":"Cancer Cell"},{"key":"1066_CR30","author":"M Dewerchin","year":"2012","unstructured":"Dewerchin M, Carmeliet P (2012) PlGF: a multitasking cytokine with disease-restricted activity. Cold Spring Harb Perspect Med. doi: 10.1101\/cshperspect.a011056","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1066_CR31","doi-asserted-by":"crossref","unstructured":"Dieterich LC, Mellberg S, Langenkamp E et al (2012) Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGF\u03b22 in vascular abnormalization. J Pathol. doi: 10.1002\/path.4072","DOI":"10.1002\/path.4072"},{"issue":"3","key":"1066_CR32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.RES.86.3.286","volume":"86","author":"V Djonov","year":"2000","unstructured":"Djonov V, Schmid M, Tschanz SA, Burri PH (2000) Intussusceptive angiogenesis: its role in embryonic vascular network formation. Circ Res 86(3):286\u2013292","journal-title":"Circ Res"},{"issue":"16","key":"1066_CR33","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1101\/gad.8.16.1897","volume":"8","author":"DJ Dumont","year":"1994","unstructured":"Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML (1994) Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8(16):1897\u20131909","journal-title":"Genes Dev"},{"issue":"8","key":"1066_CR34","first-page":"1471","volume":"7","author":"DJ Dumont","year":"1992","unstructured":"Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML (1992) tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 7(8):1471\u20131480","journal-title":"Oncogene"},{"issue":"3","key":"1066_CR35","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2009.01.021","volume":"15","author":"JML Ebos","year":"2009","unstructured":"Ebos JML, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS (2009) Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15(3):232\u2013239","journal-title":"Cancer Cell"},{"issue":"2","key":"1066_CR36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.22679","volume":"121","author":"C Eckerich","year":"2007","unstructured":"Eckerich C, Zapf S, Fillbrandt R, Loges S, Westphal M, Lamszus K (2007) Hypoxia can induce c-Met expression in glioma cells and enhance SF\/HGF-induced cell migration. Int J Cancer 121(2):276\u2013283","journal-title":"Int J Cancer"},{"key":"1066_CR37","author":"A Eichmann","year":"2012","unstructured":"Eichmann A, Thomas J-L (2012) Molecular parallels between neural and vascular development. Cold Spring Harb Perspect Med. doi: 10.1101\/cshperspect.a006551","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"1066_CR38","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","volume":"2","author":"N Ferrara","year":"2002","unstructured":"Ferrara N (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2(10):795\u2013803","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1066_CR39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm1351","volume":"12","author":"U Fiedler","year":"2006","unstructured":"Fiedler U, Reiss Y, Scharpfenecker M et al (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12(2):235\u2013239","journal-title":"Nat Med"},{"issue":"3","key":"1066_CR40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","volume":"131","author":"C Fischer","year":"2007","unstructured":"Fischer C, Jonckx B, Mazzone M et al (2007) Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131(3):463\u2013475","journal-title":"Cell"},{"issue":"21","key":"1066_CR41","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285(21):1182\u20131186","journal-title":"N Engl J Med"},{"issue":"6535","key":"1066_CR42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/376066a0","volume":"376","author":"GH Fong","year":"1995","unstructured":"Fong GH, Rossant J, Gertsenstein M, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376(6535):66\u201370","journal-title":"Nature"},{"issue":"13","key":"1066_CR43","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1242\/dev.126.13.3015","volume":"126","author":"GH Fong","year":"1999","unstructured":"Fong GH, Zhang L, Bryce DM, Peng J (1999) Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 126(13):3015\u20133025","journal-title":"Development"},{"issue":"29","key":"1066_CR44","doi-asserted-by":"crossref","first-page":"24821","DOI":"10.1074\/jbc.M111.334540","volume":"287","author":"R Francescone","year":"2012","unstructured":"Francescone R, Scully S, Bentley B, Yan W, Taylor SL, Oh D, Moral L, Shao R (2012) Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation. J Biol Chem 287(29):24821\u201324831","journal-title":"J Biol Chem"},{"issue":"9","key":"1066_CR45","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.bjc.6605925","volume":"103","author":"V Goede","year":"2010","unstructured":"Goede V, Coutelle O, Neuneier J et al (2010) Identification of serum Angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy. Br J Cancer 103(9):1407\u20131414","journal-title":"Br J Cancer"},{"issue":"6","key":"1066_CR46","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1215\/15228517-2008-061","volume":"10","author":"C Gomez-Manzano","year":"2008","unstructured":"Gomez-Manzano C, Holash J, Fueyo J, Xu J, Conrad CA, Aldape KD, de Groot JF, Bekele BN, Yung WKA (2008) VEGF Trap induces antiglioma effect at different stages of disease. Neuro Oncol 10(6):940\u2013945","journal-title":"Neuro Oncol"},{"issue":"6","key":"1066_CR47","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883\u2013899","journal-title":"Cell"},{"issue":"1","key":"1066_CR48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cell.2005.10.036","volume":"124","author":"M Grunewald","year":"2006","unstructured":"Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S, Chimenti S, Landsman L, Abramovitch R, Keshet E (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124(1):175\u2013189","journal-title":"Cell"},{"issue":"3","key":"1066_CR49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.20111424","volume":"209","author":"P Hamerlik","year":"2012","unstructured":"Hamerlik P, Lathia JD, Rasmussen R et al (2012) Autocrine VEGF\u2013VEGFR2\u2013Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth. J Exp Med 209(3):507\u2013520","journal-title":"J Exp Med"},{"issue":"5322","key":"1066_CR50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1126\/science.277.5322.48","volume":"277","author":"D Hanahan","year":"1997","unstructured":"Hanahan D (1997) Signaling vascular morphogenesis and maintenance. Science 277(5322):48\u201350","journal-title":"Science"},{"issue":"2","key":"1066_CR51","first-page":"368","volume":"146","author":"E Hatva","year":"1995","unstructured":"Hatva E, Kaipainen A, Mentula P, J\u00e4\u00e4skel\u00e4inen J, Paetau A, Haltia M, Alitalo K (1995) Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 146(2):368\u2013378","journal-title":"Am J Pathol"},{"issue":"4","key":"1066_CR52","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1582-4934.2010.01091.x","volume":"15","author":"T He","year":"2011","unstructured":"He T, Smith N, Saunders D et al (2011) Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas. J Cell Mol Med 15(4):837\u2013849","journal-title":"J Cell Mol Med"},{"issue":"21","key":"1066_CR53","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1200\/JCO.2008.19.6683","volume":"27","author":"RS Herbst","year":"2009","unstructured":"Herbst RS, Hong D, Chap L et al (2009) Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors. J Clin Oncol 27(21):3557\u20133565","journal-title":"J Clin Oncol"},{"key":"1066_CR54","author":"IA Ho","year":"2012","unstructured":"Ho IA, Toh HC, Ng WH, Teo YL, Guo CM, Hui KM, Lam PY (2012) Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells. doi: 10.1002\/stem.1247","journal-title":"Stem Cells"},{"issue":"17","key":"1066_CR55","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1073\/pnas.172398299","volume":"99","author":"J Holash","year":"2002","unstructured":"Holash J (2002) VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci USA 99(17):11393\u201311398","journal-title":"Proc Natl Acad Sci USA"},{"issue":"38","key":"1066_CR56","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1038\/sj.onc.1203035","volume":"18","author":"J Holash","year":"1999","unstructured":"Holash J, Wiegand SJ, Yancopoulos GD (1999) New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18(38):5356\u20135362","journal-title":"Oncogene"},{"issue":"6","key":"1066_CR57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jnci\/djs009","volume":"104","author":"T Holopainen","year":"2012","unstructured":"Holopainen T, Saharinen P, D\u2019Amico G et al (2012) Effects of Angiopoietin-2-blocking antibody on endothelial cell\u2013cell junctions and lung metastasis. J Natl Cancer Inst 104(6):461\u2013475","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"1066_CR58","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrc2894","volume":"10","author":"H Huang","year":"2010","unstructured":"Huang H, Bhat A, Woodnutt G, Lappe R (2010) Targeting the ANGPT\u2013TIE2 pathway in malignancy. Nat Rev Cancer 10(8):575\u2013585","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1066_CR59","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1158\/1078-0432.CCR-10-2317","volume":"17","author":"H Huang","year":"2011","unstructured":"Huang H, Lai J-Y, Do J et al (2011) Specifically targeting Angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth. Clin Cancer Res 17(5):1001\u20131011","journal-title":"Clin Cancer Res"},{"issue":"5706","key":"1066_CR60","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307(5706):58\u201362","journal-title":"Science"},{"issue":"2","key":"1066_CR61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/72212","volume":"6","author":"RK Jain","year":"2000","unstructured":"Jain RK, Munn LL (2000) Leaky vessels? Call Ang1! Nat Med 6(2):131\u2013132","journal-title":"Nat Med"},{"issue":"6","key":"1066_CR62","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.cell.2012.05.025","volume":"149","author":"RK Jain","year":"2012","unstructured":"Jain RK, Carmeliet P (2012) SnapShot: tumor angiogenesis. Cell 149(6):1408\u20131408.e1","journal-title":"Cell"},{"issue":"18","key":"1066_CR63","doi-asserted-by":"crossref","first-page":"11946","DOI":"10.1073\/pnas.182296499","volume":"99","author":"K Jin","year":"2002","unstructured":"Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA (2002) Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 99(18):11946\u201311950","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1066_CR64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/35067005","volume":"2","author":"N Jones","year":"2001","unstructured":"Jones N, Iljin K, Dumont DJ, Alitalo K (2001) Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2(4):257\u2013267","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"1066_CR65","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1365-2559.2011.04138.x","volume":"60","author":"AM Jubb","year":"2012","unstructured":"Jubb AM, Browning L, Campo L, Turley H, Steers G, Thurston G, Harris AL, Ansorge O (2012) Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma. Histopathology 60(5):740\u2013747","journal-title":"Histopathology"},{"issue":"19","key":"1066_CR66","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","volume":"358","author":"RS Kerbel","year":"2008","unstructured":"Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358(19):2039\u20132049","journal-title":"N Engl J Med"},{"issue":"18","key":"1066_CR67","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1158\/0008-5472.CAN-07-6241","volume":"68","author":"M Kerber","year":"2008","unstructured":"Kerber M, Reiss Y, Wickersheim A et al (2008) Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res 68(18):7342\u20137351","journal-title":"Cancer Res"},{"issue":"9","key":"1066_CR68","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1073\/pnas.1014480108","volume":"108","author":"O Keunen","year":"2011","unstructured":"Keunen O, Johansson M, Oudin A et al (2011) Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci USA 108(9):3749\u20133754","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"1066_CR69","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1182\/blood-2011-09-377333","volume":"118","author":"H Kim","year":"2011","unstructured":"Kim H, Koh GY (2011) Ang2, the instigator of inflammation. Blood 118(18):4767\u20134768","journal-title":"Blood"},{"issue":"1","key":"1066_CR70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/08977199209023937","volume":"7","author":"KJ Kim","year":"1992","unstructured":"Kim KJ, Li B, Houck K, Winer J, Ferrara N (1992) The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 7(1):53\u201364","journal-title":"Growth Factors"},{"issue":"6423","key":"1066_CR71","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/362841a0","volume":"362","author":"KJ Kim","year":"1993","unstructured":"Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362(6423):841\u2013844","journal-title":"Nature"},{"issue":"3","key":"1066_CR72","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1172\/JCI40283","volume":"120","author":"M Kioi","year":"2010","unstructured":"Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM (2010) Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 120(3):694\u2013705","journal-title":"J Clin Invest"},{"issue":"2","key":"1066_CR73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ccr.2010.07.001","volume":"18","author":"YJ Koh","year":"2010","unstructured":"Koh YJ, Kim HZ, Hwang S-I et al (2010) Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage. Cancer Cell 18(2):171\u2013184","journal-title":"Cancer Cell"},{"issue":"25","key":"1066_CR74","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1161\/CIRCULATIONAHA.112.112755","volume":"125","author":"C Korn","year":"2012","unstructured":"Korn C, Augustin HG (2012) Born to die: blood vessel regression research coming of age. Circulation 125(25):3063\u20133065","journal-title":"Circulation"},{"issue":"7","key":"1066_CR75","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrc2007-c1","volume":"11","author":"SV Kozin","year":"2011","unstructured":"Kozin SV, Duda DG, Munn LL, Jain RK (2011) Is vasculogenesis crucial for the regrowth of irradiated tumours? Nat Rev Cancer 11(7):532","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"1066_CR76","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1158\/0008-5472.CAN-09-4446","volume":"70","author":"SV Kozin","year":"2010","unstructured":"Kozin SV, Kamoun WS, Huang Y, Dawson MR, Jain RK, Duda DG (2010) Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation. Cancer Res 70(14):5679\u20135685","journal-title":"Cancer Res"},{"issue":"2","key":"1066_CR77","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000332849","volume":"81","author":"EA Kuczynski","year":"2011","unstructured":"Kuczynski EA, Patten SG, Coomber BL (2011) VEGFR2 expression and TGF-\u03b2 signaling in initial and recurrent high-grade human glioma. Oncology 81(2):126\u2013134","journal-title":"Oncology"},{"issue":"1","key":"1066_CR78","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2045-824X-3-20","volume":"3","author":"F Kuhnert","year":"2011","unstructured":"Kuhnert F, Kirshner JR, Thurston G (2011) Dll4-Notch signaling as a therapeutic target in tumor angiogenesis. Vascular Cell 3(1):20","journal-title":"Vascular Cell"},{"issue":"8","key":"1066_CR79","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2176\/nmc.52.539","volume":"52","author":"K Kurozumi","year":"2012","unstructured":"Kurozumi K, Ichikawa T, Onishi M, Fujii K, Date I (2012) Cilengitide treatment for malignant glioma: current status and future direction. Neurol Med Chir (Tokyo) 52(8):539\u2013547","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"3","key":"1066_CR80","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/cne.1066","volume":"436","author":"H Kurz","year":"2001","unstructured":"Kurz H, Korn J, Eggli PS, Huang R, Christ B (2001) Embryonic central nervous system angiogenesis does not involve blood-borne endothelial progenitors. J Comp Neurol 436(3):263\u2013274","journal-title":"J Comp Neurol"},{"key":"1066_CR81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-4419-8871-3_2","volume":"117","author":"H Kurz","year":"2004","unstructured":"Kurz H, Korn J, Christ B (2004) Morphogenesis of embryonic CNS vessels. Cancer Treat Res 117:33\u201350","journal-title":"Cancer Treat Res"},{"issue":"5","key":"1066_CR82","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1186\/cc10523","volume":"15","author":"P K\u00fcmpers","year":"2011","unstructured":"K\u00fcmpers P, Gueler F, David S et al (2011) The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Crit Care 15(5):R261","journal-title":"Crit Care"},{"issue":"4","key":"1066_CR83","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ng1211","volume":"34","author":"D Lambrechts","year":"2003","unstructured":"Lambrechts D, Storkebaum E, Morimoto M et al (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34(4):383\u2013394","journal-title":"Nat Genet"},{"issue":"4","key":"1066_CR84","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cell.2007.06.054","volume":"130","author":"S Lee","year":"2007","unstructured":"Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130(4):691\u2013703","journal-title":"Cell"},{"issue":"20","key":"1066_CR85","first-page":"4625","volume":"56","author":"RD Leek","year":"1996","unstructured":"Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56(20):4625\u20134629","journal-title":"Cancer Res"},{"issue":"5","key":"1066_CR86","first-page":"1321","volume":"40","author":"CC Leow","year":"2012","unstructured":"Leow CC, Coffman K, Inigo I et al (2012) MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models. Int J Oncol 40(5):1321\u20131330","journal-title":"Int J Oncol"},{"issue":"8","key":"1066_CR87","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/00000478-199708000-00009","volume":"21","author":"SY Leung","year":"1997","unstructured":"Leung SY, Chan AS, Wong MP, Yuen ST, Cheung N, Chung LP (1997) Expression of vascular endothelial growth factor and its receptors in pilocytic astrocytoma. Am J Surg Pathol 21(8):941\u2013950","journal-title":"Am J Surg Pathol"},{"issue":"18","key":"1066_CR88","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1158\/0008-5472.CAN-07-1684","volume":"67","author":"CE Lewis","year":"2007","unstructured":"Lewis CE, De Palma M, Naldini L (2007) Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and Angiopoietin-2. Cancer Res 67(18):8429\u20138432","journal-title":"Cancer Res"},{"issue":"2","key":"1066_CR89","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11060-011-0578-5","volume":"105","author":"X-M Liu","year":"2011","unstructured":"Liu X-M, Zhang Q-P, Mu Y-G, Zhang X-H, Sai K, Pang JC-S, Ng H-K, Chen Z-P (2011) Clinical significance of vasculogenic mimicry in human gliomas. J Neurooncol 105(2):173\u2013179","journal-title":"J Neurooncol"},{"issue":"8","key":"1066_CR90","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-11-2175","volume":"18","author":"JM Llovet","year":"2012","unstructured":"Llovet JM, Pe\u00f1a CEA, Lathia CD, Shan M, Meinhardt G, Bruix J, SHARP Investigators Study Group (2012) Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma. Clin Cancer Res 18(8):2290\u20132300","journal-title":"Clin Cancer Res"},{"issue":"11","key":"1066_CR91","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1158\/1078-0432.CCR-08-2276","volume":"15","author":"S Loges","year":"2009","unstructured":"Loges S, Schmidt T, Carmeliet P (2009) \u201cAntimyeloangiogenic\u201d therapy for cancer by inhibiting PlGF. Clin Cancer Res 15(11):3648\u20133653","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1066_CR92","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccr.2012.05.037","volume":"22","author":"KV Lu","year":"2012","unstructured":"Lu KV, Chang JP, Parachoniak CA et al (2012) VEGF inhibits tumor cell invasion and mesenchymal transition through a MET\/VEGFR2 complex. Cancer Cell 22(1):21\u201335","journal-title":"Cancer Cell"},{"issue":"4","key":"1066_CR93","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1750-3639.2003.tb00487.x","volume":"13","author":"MR Machein","year":"2003","unstructured":"Machein MR, Renninger S, de Lima-Hahn E, Plate KH (2003) Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas. Brain Pathol 13(4):582\u2013597","journal-title":"Brain Pathol"},{"issue":"5322","key":"1066_CR94","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre PC, Suri C, Jones PF et al (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277(5322):55\u201360","journal-title":"Science"},{"issue":"3","key":"1066_CR95","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","volume":"155","author":"AJ Maniotis","year":"1999","unstructured":"Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe\u2019er J, Trent JM, Meltzer PS, Hendrix MJ (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155(3):739\u2013752","journal-title":"Am J Pathol"},{"key":"1066_CR96","author":"T Matsubara","year":"2012","unstructured":"Matsubara T, Kanto T, Kuroda S et al (2012) TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlated with angiogenesis. Hepatology. doi: 10.1002\/hep.25965","journal-title":"Hepatology"},{"issue":"4","key":"1066_CR97","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ccr.2011.03.016","volume":"19","author":"R Mazzieri","year":"2011","unstructured":"Mazzieri R, Pucci F, Moi D et al (2011) Targeting the ANG2\/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 19(4):431\u2013433","journal-title":"Cancer Cell"},{"issue":"1\u20132","key":"1066_CR98","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1026529222845","volume":"19","author":"DM McDonald","year":"2000","unstructured":"McDonald DM, Foss AJ (2000) Endothelial cells of tumor vessels: abnormal but not absent. Cancer Metastasis Rev 19(1\u20132):109\u2013120","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"1066_CR99","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0002-9440(10)64740-2","volume":"156","author":"DM McDonald","year":"2000","unstructured":"McDonald DM, Munn L, Jain RK (2000) Vasculogenic mimicry: how convincing, how novel, and how significant? Am J Pathol 156(2):383\u2013388","journal-title":"Am J Pathol"},{"key":"1066_CR100","author":"KL Meadows","year":"2012","unstructured":"Meadows KL, Hurwitz HI (2012) Anti-VEGF therapies in the clinic. Cold Spring Harb Perspect Med. doi: 10.1101\/cshperspect.a006577","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"8","key":"1066_CR101","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nrc2444","volume":"8","author":"C Murdoch","year":"2008","unstructured":"Murdoch C, Muthana M, Coffelt SB, Lewis CE (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8(8):618\u2013631","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1066_CR102","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3171\/2011.9.JNS11656","volume":"116","author":"A Narayana","year":"2012","unstructured":"Narayana A, Gruber D, Kunnakkat S, Golfinos JG, Parker E, Raza S, Zagzag D, Eagan P, Gruber ML (2012) A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma. J Neurosurg 116(2):341\u2013345","journal-title":"J Neurosurg"},{"issue":"1","key":"1066_CR103","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11060-011-0642-1","volume":"106","author":"AD Norden","year":"2012","unstructured":"Norden AD, Bartolomeo J, Tanaka S et al (2012) Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients. J Neurooncol 106(1):121\u2013125","journal-title":"J Neurooncol"},{"issue":"11","key":"1066_CR104","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrneurol.2009.159","volume":"5","author":"AD Norden","year":"2009","unstructured":"Norden AD, Drappatz J, Wen PY (2009) Antiangiogenic therapies for high-grade glioma. Nat Rev Neurol 5(11):610\u2013620","journal-title":"Nat Rev Neurol"},{"key":"1066_CR105","author":"M Onishi","year":"2012","unstructured":"Onishi M, Ichikawa T, Kurozumi K, Fujii K, Yoshida K, Inoue S, Michiue H, Chiocca EA, Kaur B, Date I (2012) Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models. Neuropathology. doi: 10.1111","journal-title":"Neuropathology"},{"issue":"2","key":"1066_CR106","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","volume":"28","author":"B Oosthuyse","year":"2001","unstructured":"Oosthuyse B, Moons L, Storkebaum E et al (2001) Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28(2):131\u2013138","journal-title":"Nat Genet"},{"issue":"3","key":"1066_CR107","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","volume":"15","author":"M P\u00e0ez-Ribes","year":"2009","unstructured":"P\u00e0ez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vi\u00f1als F, Inoue M, Bergers G, Hanahan D, Casanovas O (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15(3):220\u2013231","journal-title":"Cancer Cell"},{"issue":"4","key":"1066_CR108","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1535-6108(03)00085-0","volume":"3","author":"S Pennacchietti","year":"2003","unstructured":"Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3(4):347\u2013361","journal-title":"Cancer Cell"},{"key":"1066_CR109","author":"Y Piao","year":"2012","unstructured":"Piao Y, Liang J, Holmes L, Zurita AJ, Henry V, Heymach JV, de Groot JF (2012) Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro Oncol. doi: 10.1093\/neuonc\/nos158","journal-title":"Neuro Oncol"},{"issue":"4","key":"1066_CR110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00005072-199904000-00001","volume":"58","author":"KH Plate","year":"1999","unstructured":"Plate KH (1999) Mechanisms of angiogenesis in the brain. J Neuropathol Exp Neurol 58(4):313\u2013320","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"1066_CR111","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1750-3639.1994.tb00835.x","volume":"4","author":"KH Plate","year":"1994","unstructured":"Plate KH, Breier G, Risau W (1994) Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 4(3):207\u2013218","journal-title":"Brain Pathol"},{"issue":"23","key":"1066_CR112","first-page":"5822","volume":"53","author":"KH Plate","year":"1993","unstructured":"Plate KH, Breier G, Millauer B, Ullrich A, Risau W (1993) Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53(23):5822\u20135827","journal-title":"Cancer Res"},{"issue":"6398","key":"1066_CR113","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/359845a0","volume":"359","author":"KH Plate","year":"1992","unstructured":"Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359(6398):845\u2013848","journal-title":"Nature"},{"issue":"4","key":"1066_CR114","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ijc.2910590415","volume":"59","author":"KH Plate","year":"1994","unstructured":"Plate KH, Breier G, Weich HA, Mennel HD, Risau W (1994) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59(4):520\u2013529","journal-title":"Int J Cancer"},{"issue":"6","key":"1066_CR115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00401-007-0228-3","volume":"113","author":"S Raab","year":"2007","unstructured":"Raab S, Plate KH (2007) Different networks, common growth factors: shared growth factors and receptors of the vascular and the nervous system. Acta Neuropathol 113(6):607\u2013626","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1066_CR116","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1160\/TH03-09-0582","volume":"91","author":"S Raab","year":"2004","unstructured":"Raab S, Beck H, Gaumann A, Y\u00fcce A, Gerber H-P, Plate K, Hammes H-P, Ferrara N, Breier G (2004) Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor. Thromb Haemost 91(3):595\u2013605","journal-title":"Thromb Haemost"},{"issue":"7","key":"1066_CR117","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2012.64","volume":"9","author":"A Rapisarda","year":"2012","unstructured":"Rapisarda A, Melillo G (2012) Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia. Nat Rev Clin Oncol 9(7):378\u2013390","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"1066_CR118","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1084\/jem.20111580","volume":"209","author":"M Reis","year":"2012","unstructured":"Reis M, Czupalla CJ, Ziegler N et al (2012) Endothelial Wnt\/\u00df-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression. J Exp Med 209(9):1611\u20131627","journal-title":"J Exp Med"},{"issue":"2","key":"1066_CR119","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2011.10.040","volume":"316","author":"D Ribatti","year":"2012","unstructured":"Ribatti D, Djonov V (2012) Intussusceptive microvascular growth in tumors. Cancer Lett 316(2):126\u2013131","journal-title":"Cancer Lett"},{"issue":"7325","key":"1066_CR120","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nature09557","volume":"468","author":"L Ricci-Vitiani","year":"2010","unstructured":"Ricci-Vitiani L, Pallini R, Biffoni M et al (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468(7325):824\u2013828","journal-title":"Nature"},{"issue":"6626","key":"1066_CR121","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","volume":"386","author":"W Risau","year":"1997","unstructured":"Risau W (1997) Mechanisms of angiogenesis. Nature 386(6626):671\u2013674","journal-title":"Nature"},{"issue":"20","key":"1066_CR122","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1101\/gad.1589207","volume":"21","author":"C Roca","year":"2007","unstructured":"Roca C, Adams RH (2007) Regulation of vascular morphogenesis by Notch signaling. Genes Dev 21(20):2511\u20132524","journal-title":"Genes Dev"},{"issue":"1","key":"1066_CR123","doi-asserted-by":"crossref","first-page":"98","DOI":"10.18632\/oncotarget.427","volume":"3","author":"FJ Rodriguez","year":"2012","unstructured":"Rodriguez FJ, Orr BA, Ligon KL, Eberhart CG (2012) Neoplastic cells are a rare component in human glioblastoma microvasculature. Oncotarget 3(1):98\u2013106","journal-title":"Oncotarget"},{"issue":"2","key":"1066_CR124","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4161\/org.6.2.11687","volume":"6","author":"JM Rosenstein","year":"2010","unstructured":"Rosenstein JM, Krum JM, Ruhrberg C (2010) VEGF in the nervous system. Organogenesis 6(2):107\u2013114","journal-title":"Organogenesis"},{"issue":"2","key":"1066_CR125","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physrev.00031.2008","volume":"89","author":"C Ruiz de Almodovar","year":"2009","unstructured":"Ruiz de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P (2009) Role and therapeutic potential of VEGF in the nervous system. Physiol Rev 89(2):607\u2013648","journal-title":"Physiol Rev"},{"issue":"10","key":"1066_CR126","first-page":"4213","volume":"32","author":"C Scaringi","year":"2012","unstructured":"Scaringi C, Minniti G, Caporello P, Enrici RM (2012) Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results. Anticancer Res 32(10):4213\u20134223","journal-title":"Anticancer Res"},{"issue":"3","key":"1066_CR127","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1750-3639.2004.tb00060.x","volume":"14","author":"A Schanzer","year":"2004","unstructured":"Schanzer A, Wachs F-P, Wilhelm D, Acker T, Cooper-Kuhn C, Beck H, Winkler J, Aigner L, Plate KH, Kuhn HG (2004) Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol 14(3):237\u2013248","journal-title":"Brain Pathol"},{"issue":"18","key":"1066_CR128","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1182\/blood-2011-03-343293","volume":"118","author":"A Scholz","year":"2011","unstructured":"Scholz A, Lang V, Henschler R et al (2011) Angiopoietin-2 promotes myeloid cell infiltration in a \u03b22-integrin-dependent manner. Blood 118(18):5050\u20135059","journal-title":"Blood"},{"issue":"10","key":"1066_CR129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrc3366","volume":"12","author":"B Sennino","year":"2012","unstructured":"Sennino B, McDonald DM (2012) Controlling escape from angiogenesis inhibitors. Nat Rev Cancer 12(10):699\u2013709","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1066_CR130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/2159-8290.CD-11-0240","volume":"2","author":"B Sennino","year":"2012","unstructured":"Sennino B, Ishiguro-Oonuma T, Wei Y et al (2012) Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Cancer Discov 2(3):270\u2013287","journal-title":"Cancer Discov"},{"issue":"5","key":"1066_CR131","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1517\/13543784.2012.670219","volume":"21","author":"K Seystahl","year":"2012","unstructured":"Seystahl K, Weller M (2012) Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma? Expert Opin Investig Drugs 21(5):605\u2013617","journal-title":"Expert Opin Investig Drugs"},{"issue":"8","key":"1066_CR132","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/ijc.24506","volume":"125","author":"I Shabo","year":"2009","unstructured":"Shabo I, Olsson H, Sun X-F, Svanvik J (2009) Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. Int J Cancer 125(8):1826\u20131831","journal-title":"Int J Cancer"},{"issue":"6535","key":"1066_CR133","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/376062a0","volume":"376","author":"F Shalaby","year":"1995","unstructured":"Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376(6535):62\u201366","journal-title":"Nature"},{"issue":"6398","key":"1066_CR134","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","volume":"359","author":"D Shweiki","year":"1992","unstructured":"Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398):843\u2013845","journal-title":"Nature"},{"issue":"6","key":"1066_CR135","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","volume":"42","author":"A Sica","year":"2006","unstructured":"Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42(6):717\u2013727","journal-title":"Eur J Cancer"},{"issue":"5","key":"1066_CR136","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2990.2011.01160.x","volume":"37","author":"AH Sikkema","year":"2011","unstructured":"Sikkema AH, de Bont ESJM, Molema G, Dimberg A, Zwiers PJ, Diks SH, Hoving EW, Kamps WA, Peppelenbosch MP, den Dunnen WFA (2011) Vascular endothelial growth factor receptor 2 (VEGFR-2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells. Neuropathol Appl Neurobiol 37(5):538\u2013548","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8","key":"1066_CR137","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1158\/0008-5472.CAN-11-3406","volume":"72","author":"B Sitohy","year":"2012","unstructured":"Sitohy B, Nagy JA, Dvorak HF (2012) Anti-VEGF\/VEGFR therapy for cancer: reassessing the target. Cancer Res 72(8):1909\u20131914","journal-title":"Cancer Res"},{"issue":"2","key":"1066_CR138","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1158\/0008-5472.CAN-11-2464","volume":"72","author":"AG Sorensen","year":"2012","unstructured":"Sorensen AG, Emblem KE, Polaskova P et al (2012) Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. Cancer Res 72(2):402\u2013407","journal-title":"Cancer Res"},{"issue":"10","key":"1066_CR139","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","volume":"362","author":"C Steidl","year":"2010","unstructured":"Steidl C, Lee T, Shah SP et al (2010) Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma. N Engl J Med 362(10):875\u2013885","journal-title":"N Engl J Med"},{"issue":"1","key":"1066_CR140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nn1360","volume":"8","author":"E Storkebaum","year":"2005","unstructured":"Storkebaum E, Lambrechts D, Dewerchin M et al (2005) Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 8(1):85\u201392","journal-title":"Nat Neurosci"},{"issue":"5","key":"1066_CR141","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0002-9440(10)65733-1","volume":"153","author":"A Stratmann","year":"1998","unstructured":"Stratmann A, Risau W, Plate KH (1998) Cell type-specific expression of Angiopoietin-1 and Angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 153(5):1459\u20131466","journal-title":"Am J Pathol"},{"issue":"1","key":"1066_CR142","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/WNL.0b013e318204a3af","volume":"76","author":"EM Thompson","year":"2011","unstructured":"Thompson EM, Frenkel EP, Neuwelt EA (2011) The paradoxical effect of bevacizumab in the therapy of malignant gliomas. Neurology 76(1):87\u201393","journal-title":"Neurology"},{"issue":"2","key":"1066_CR143","first-page":"a006601","volume":"2","author":"JJ Tung","year":"2012","unstructured":"Tung JJ, Tattersall IW, Kitajewski J (2012) Tips, stalks, tubes: Notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis. Cold Spring Harb Perspect Med 2(2):a006601","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"1066_CR144","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1073\/pnas.96.5.1904","volume":"96","author":"DM Valenzuela","year":"1999","unstructured":"Valenzuela DM, Griffiths JA, Rojas J et al (1999) Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci USA 96(5):1904\u20131909","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1066_CR145","doi-asserted-by":"crossref","first-page":"e38399","DOI":"10.1371\/journal.pone.0038399","volume":"7","author":"EL Agtmaal van","year":"2012","unstructured":"van Agtmaal EL, Bierings R, Dragt BS, Leyen TA, Fernandez-Borja M, Horrevoets AJG, Voorberg J (2012) The shear stress-induced transcription factor KLF2 affects dynamics and Angiopoietin-2 content of Weibel-Palade bodies. PLoS One 7(6):e38399","journal-title":"PLoS One"},{"issue":"Pt 9","key":"1066_CR146","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1093\/brain\/aws145","volume":"135","author":"A Verheyen","year":"2012","unstructured":"Verheyen A, Peeraer E, Nuydens R et al (2012) Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy. Brain 135(Pt 9):2629\u20132641","journal-title":"Brain"},{"issue":"30","key":"1066_CR147","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1200\/JCO.2007.12.2440","volume":"25","author":"JJ Vredenburgh","year":"2007","unstructured":"Vredenburgh JJ, Desjardins A, Herndon JE et al (2007) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25(30):4722\u20134729","journal-title":"J Clin Oncol"},{"issue":"7325","key":"1066_CR148","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09624","volume":"468","author":"R Wang","year":"2010","unstructured":"Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C, Tabar V (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468(7325):829\u2013833","journal-title":"Nature"},{"issue":"15","key":"1066_CR149","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1523\/JNEUROSCI.22-15-06401.2002","volume":"22","author":"A Wick","year":"2002","unstructured":"Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz JB (2002) Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 22(15):6401\u20136407","journal-title":"J Neurosci"},{"issue":"4","key":"1066_CR150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/01.RES.81.4.567","volume":"81","author":"AL Wong","year":"1997","unstructured":"Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG (1997) Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 81(4):567\u2013574","journal-title":"Circ Res"},{"issue":"20","key":"1066_CR151","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.1158\/0008-5472.CAN-09-2099","volume":"69","author":"L Xu","year":"2009","unstructured":"Xu L, Duda DG, di Tomaso E et al (2009) Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. Cancer Res 69(20):7905\u20137910","journal-title":"Cancer Res"},{"issue":"7282","key":"1066_CR152","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1038\/nature08751","volume":"463","author":"M Yan","year":"2010","unstructured":"Yan M, Callahan CA, Beyer JC, Allamneni KP, Zhang G, Ridgway JB, Niessen K, Plowman GD (2010) Chronic DLL4 blockade induces vascular neoplasms. Nature 463(7282):E6\u2013E7","journal-title":"Nature"},{"issue":"19","key":"1066_CR153","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1523\/JNEUROSCI.16-19-06089.1996","volume":"16","author":"X Yang","year":"1996","unstructured":"Yang X, Cepko CL (1996) Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J Neurosci 16(19):6089\u20136099","journal-title":"J Neurosci"},{"issue":"14","key":"1066_CR154","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1158\/0008-5472.CAN-10-2527","volume":"71","author":"W-K You","year":"2011","unstructured":"You W-K, Sennino B, Williamson CW, Falc\u00f3n B, Hashizume H, Yao L-C, Aftab DT, McDonald DM (2011) VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer. Cancer Res 71(14):4758\u20134768","journal-title":"Cancer Res"},{"issue":"8","key":"1066_CR155","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1369\/jhc.4A6521.2005","volume":"53","author":"W-Y Yue","year":"2005","unstructured":"Yue W-Y, Chen Z-P (2005) Does vasculogenic mimicry exist in astrocytoma? J Histochem Cytochem 53(8):997\u20131002","journal-title":"J Histochem Cytochem"},{"issue":"11","key":"1066_CR156","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W","volume":"88","author":"D Zagzag","year":"2000","unstructured":"Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL (2000) Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88(11):2606\u20132618","journal-title":"Cancer"},{"issue":"4","key":"1066_CR157","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s12032-010-9638-5","volume":"28","author":"BC Zhang","year":"2011","unstructured":"Zhang BC, Gao J, Wang J, Rao ZG, Wang BC, Gao JF (2011) Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma. Med Oncol 28(4):1447\u20131452","journal-title":"Med Oncol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-012-1066-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-1066-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-1066-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T22:38:32Z","timestamp":1643582312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-012-1066-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,11]]},"references-count":157,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1066"],"URL":"https:\/\/doi.org\/10.1007\/s00401-012-1066-5","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,11]]}}}